Cibc Private Wealth Group, LLC Immuneering Corp Transaction History

Cibc Private Wealth Group, LLC

  • $56.1 Billion
  • Q3 2025

A detailed history of Cibc Private Wealth Group, LLC transactions in Immuneering Corp stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 50,051 shares of IMRX stock, worth $320,326. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,051
Previous 10,000 400.51%
Holding current value
$320,326
Previous $15,000 2080.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 21, 2025
BUY
$3.04 - $9.26 $121,755 - $370,872
40,051 Added 400.51%
50,051 $327,000
Q3 2024

Nov 13, 2024
BUY
$1.03 - $3.21 $10,300 - $32,100
10,000 New
10,000 $24,000

Others Institutions Holding IMRX

# of Institutions
69
Shares Held
14.5M
Call Options Held
0
Put Options Held
0
View Full List

About Immuneering Corp

IMRX Quotes by TradingView
  • Ticker IMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,392,300
  • Market Cap $169M
  • Description
  • Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...
More about IMRX
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email